In 2009, von Maltzahn joined Noubar Afeyan and David Berry in Flagship VentureLabs, where he began studying the pharmacology of nutrition and devising systems to efficiently produce essential and performance nutrients for a variety of health needs.
Helicos was co-founded in 2003 by life science entrepreneur Stanley Lapidus, Stephen Quake, and Noubar Afeyan with investments from Atlas Venture, Flagship Ventures, Highland Capital Partners, MPM Capital, and Versant Ventures.
Joule Unlimited was founded within Flagship VentureLabs by Noubar Afeyan and David Berry (inventor).
Founded in 2011 by Harvard chemist David R. Liu and Noubar Afeyan, CEO of Flagship Ventures, the company’s develops a class of proteins, under the trademark Intraphilin™, that enable the transport of large molecules such as antibodies into cells, thereby potentially enabling new classes of intracellular therapies.